Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 18/20 | 0.56 |
| ▸ | CNR1 | P21554 | 6/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5570158 | 0.90 | CNR2 (0.56) | CNR2CNR1KMT2AMEN1 | |
| SCHEMBL11907352 | 0.87 | CNR2 (0.58) | CNR2CNR1KMT2AMEN1ALDH1A1 | |
| SCHEMBL2746373 | 0.87 | CNR2 (0.62) | CNR2CNR1KMT2AMEN1ALDH1A1 | |
| SCHEMBL11907798 | 0.86 | CNR2 (0.45) | CNR2CNR1KMT2AMEN1 | |
| SCHEMBL11906095 | 0.85 | CNR2 (0.60) | CNR2CNR1 | |
| SCHEMBL11907258 | 0.84 | CNR2 (0.61) | CNR2CNR1 | |
| SCHEMBL11906690 | 0.84 | CNR2 (0.61) | CNR2CNR1 | |
| SCHEMBL2737026 | 0.81 | CNR2 (0.69) | CNR2CNR1KMT2AMEN1ALDH1A1 | |
| SCHEMBL2746376 | 0.81 | CNR2 (0.55) | CNR2CNR1ALDH1A1LMNA | |
| SCHEMBL2747026 | 0.78 | CNR2 (0.61) | CNR2CNR1KMT2AMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367666-B2 | 3-carbamoyl-2-pyridone derivatives | SHIONOGI & CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20120208813-A1 | 3-CARBAMOYL-2-PYRIDONE DERIVATIVES | SHIONOGI & CO., LTD. | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208813-A1 | 3-CARBAMOYL-2-PYRIDONE DERIVATIVES | CNR2, CNR1, HRH4 | CNR2 1/4885CNR1 2/4885KMT2A 2255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.